Package 63323-771-39

{"route": ["INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "4becda8d-8042-4cf1-bef3-c0ec3c23eebe", "openfda": {"nui": ["N0000000233", "N0000175595"], "upc": ["0363323771393"], "unii": ["M801H13NRU"], "rxcui": ["485246"], "spl_set_id": ["3b594aba-e798-4105-b801-0b0d970747c1"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (63323-771-39)  / 30 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "63323-771-39", "marketing_start_date": "20170316"}], "brand_name": "Azacitidine", "product_id": "63323-771_4becda8d-8042-4cf1-bef3-c0ec3c23eebe", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "63323-771", "generic_name": "Azacitidine", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Azacitidine", "active_ingredients": [{"name": "AZACITIDINE", "strength": "100 mg/30mL"}], "application_number": "ANDA207518", "marketing_category": "ANDA", "marketing_start_date": "20170316", "listing_expiration_date": "20261231"}